Arachidin‐1, a Prenylated Stilbenoid from Peanut, Induces Apoptosis in Triple‐Negative Breast Cancer Cells

Abstract

Triple‐negative breast cancer (TNBC) is unresponsive to typical hormonal treatments, causing it to be one of the deadliest forms of breast cancer. Investigating alternative therapies to increase survival rates for this disease is essential. The goal of this study was to assess cytotoxicity and apoptosis mechanisms of prenylated stilbenoids in TNBC cells. The prenylated stilbenoids ara-chidin‐1 (A‐1) and arachidin‐3 (A‐3) are analogs of resveratrol (RES) produced in peanut upon biotic stress. The anticancer activity of A‐1 and A‐3 isolated from peanut hairy root cultures was deter-mined in TNBC cell lines MDA‐MB‐231 and MDA‐MB‐436. After 24 h of treatment, A‐1 exhibited higher cytotoxicity than A‐3 and RES with approximately 11‐fold and six‐fold lower IC50, respec-tively, in MDA‐MB‐231 cells, and nine‐fold and eight‐fold lower IC50, respectively, in MDA‐MB‐436 cells. A‐1 did not show significant cytotoxicity in the non‐cancerous cell line MCF‐10A. While A‐1 blocked cell division in G2‐M phases in the TNBC cells, it did not affect cell division in MCF‐10A cells. Furthermore, A‐1 induced caspase‐dependent apoptosis through the intrinsic pathway by activating caspase‐9 and PARP cleavage, and inhibiting survivin. In conclusion, A‐1 merits further research as a potential lead molecule for the treatment of TNBC.